M&A

R1 to acquire Humata Health to automate prior authorisations

What's the deal? R1 RCM, a healthcare revenue management company, has agreed to acquire Humata Health, a specialist in AI-powered prior authorisations. The deal folds Humata's technology into R1's Phare Operating System (Phare OS), its platform for automating the revenue cycle.

What each does: R1 builds Phare OS, an AI-first automation platform that handles pre-bill workflows for authorisation, utilisation review, documentation, and coding to prevent denials before claims are submitted. Humata offers an end-to-end tool that matches policies, connects to payers in real time, and manages requests through final approval across all specialties.

Why now? Prior authorisations are a top-three driver of claim denials and a frequent source of friction for providers, clinicians, and patients. A recent KFFDealroom has a profile for this one. Try Dealroom → survey found one-third of insured adults named prior authorisation as the biggest burden they faced accessing healthcare, especially those with chronic conditions.

What's the endgame? Humata's policy monitoring and agentic submission capabilities will feed directly into Phare Intelligence and Payer Atlas, the foundation of Phare OS. R1 says this strengthens the platform's support for payer-provider collaboration, moving the industry closer to real-time authorisations.

What changes for customers? Phare OS customers gain the ability to deploy additional modules, including Audit and Denials, with minimal extra data integration. Humata's solution claims up to a 96% first-pass approval rate, while cutting write-offs by 30%, rescheduled appointments by 83%, and staff touches by 45%.

The signal: The deal reflects a broader push to automate the administrative layer of US healthcare, where manual authorisation work drives cost and delays care. By absorbing a dedicated authorisation player, R1 is betting that consolidating these tools onto one AI platform is the path to faster, cheaper reimbursement.

Image credit: Generated with Gemini

Read more: Yahoo Finance

More top stories